These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 13456562)

  • 1. [Studies on schizophrenia. III. C14 radioactive succinic acid in the metabolism of cerebral nerve cells].
    ARNOLD OH; HOFMANN G; LEUPOLD-LOWENTHAL H
    Wien Z Nervenheilkd Grenzgeb; 1957; 13(4):370-85. PubMed ID: 13456562
    [No Abstract]   [Full Text] [Related]  

  • 2. [Investigations on the behavior of phosphoric acid compounds in the blood of schizophrenics].
    Biesold D; Weise K; Canzler E
    Psychiatr Neurol Med Psychol (Leipz); 1965 Jun; 17(6):232-9. PubMed ID: 5832598
    [No Abstract]   [Full Text] [Related]  

  • 3. Labeling of specific glucose carbons formed from succinic acid-1-C14 and -2-C14 in the diabetic dog.
    ABRAHAM S; CHAIKOFF IL
    Arch Biochem Biophys; 1952 Nov; 41(1):143-7. PubMed ID: 12997257
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research on the problem of schizophrenia using radiocarbon-labeled lysergic acid diethylamide & succinic acid].
    ARNOLD OH; HOFMANN G; LEUPOLDLOWENTHAL H
    Strahlentherapie; 1958; 107(Sonderbd. 38):59-65; discussion 66-7. PubMed ID: 13603137
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebral metabolism in male patients with schizophrenia who have seriously and dangerously violently offended: a 31P magnetic resonance spectroscopy study.
    Puri BK; Counsell SJ; Hamilton G; Bustos MG; Horrobin DF; Richardson AJ; Treasaden IH
    Prostaglandins Leukot Essent Fatty Acids; 2004 Apr; 70(4):409-11. PubMed ID: 15041035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Content and intensity of the metabolism of succinic acid in the brain during uncoupled oxidative phosphorylation].
    Eshchenko ND
    Nerv Sist; 1967; 8():64-7. PubMed ID: 5613864
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies of succinic acid effects in LDS-25 poisoning and in schizophrenia].
    ARNOLD OH; HOFMANN G
    Wien Z Nervenheilkd Grenzgeb; 1955; 11(1):92-104. PubMed ID: 14386843
    [No Abstract]   [Full Text] [Related]  

  • 8. Proposal for a noradrenaline hypothesis of schizophrenia.
    Yamamoto K; Hornykiewicz O
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):913-22. PubMed ID: 15363614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in neuroimaging in schizophrenia: magnetic resonance spectroscopy].
    Galińska B; Szulc A; Walecki J; Kubas B; Tarasów E
    Pol Merkur Lekarski; 2003 Sep; 15(87):278-80. PubMed ID: 14679857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain cell membrane motion-restricted phospholipids: a cerebral 31-phosphorus magnetic resonance spectroscopy study of patients with schizophrenia.
    Puri BK; Counsell SJ; Hamilton G
    Prostaglandins Leukot Essent Fatty Acids; 2008 Dec; 79(6):233-5. PubMed ID: 18842398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress.
    Prabakaran S; Swatton JE; Ryan MM; Huffaker SJ; Huang JT; Griffin JL; Wayland M; Freeman T; Dudbridge F; Lilley KS; Karp NA; Hester S; Tkachev D; Mimmack ML; Yolken RH; Webster MJ; Torrey EF; Bahn S
    Mol Psychiatry; 2004 Jul; 9(7):684-97, 643. PubMed ID: 15098003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic downregulation of GABAergic function in schizophrenia: potential for pharmacological intervention?
    Costa E; Grayson DR; Guidotti A
    Mol Interv; 2003 Jun; 3(4):220-9. PubMed ID: 14993449
    [No Abstract]   [Full Text] [Related]  

  • 13. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
    Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
    Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic possibilities of cysteamine in the treatment of schizophrenia.
    Pae CU; Lee C; Paik IH
    Med Hypotheses; 2007; 69(1):199-202. PubMed ID: 17166669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation kinetics of methionine5-enkephalin by select brain areas from patients with chronic schizophrenia.
    Mosnaim AD; Nguyen TD; Puente J; Wolf ME
    Am J Ther; 2008; 15(2):126-30. PubMed ID: 18356632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
    Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
    Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transitory glutathione deficit during brain development induces cognitive impairment in juvenile and adult rats: relevance to schizophrenia.
    Cabungcal JH; Preissmann D; Delseth C; Cuénod M; Do KQ; Schenk F
    Neurobiol Dis; 2007 Jun; 26(3):634-45. PubMed ID: 17459716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular brain imaging and the neurobiology and genetics of schizophrenia.
    Heinz A; Romero B; Gallinat J; Juckel G; Weinberger DR
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S152-7. PubMed ID: 14677072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O; Demily C; Thibaut F
    Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygen restriction of neonate rats elevates neuregulin-1alpha isoform levels: possible relationship to schizophrenia.
    Nadri C; Belmaker RH; Agam G
    Neurochem Int; 2007; 51(6-7):447-50. PubMed ID: 17630047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.